Skip to main content

Latest SEC Filings — Page 127

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Rocky Brands Reports Sharp Q1 Profit Decline Amid Tariff Headwinds, Initiates Share Repurchase
Form 10-QRCKY · Form 10-Q · 4d ago
AGCO Reports Strong Q1 Earnings Beat, Raises Full-Year EPS Guidance, and Authorizes $350M Share Buyback
ProForm 8-KAGCO · Form 8-K · 4d ago
SS Innovations' SSi Mantra Robotic System Surpasses 10,500 Surgeries Globally
ProForm 8-KSSII · Form 8-K · 4d ago
Disc Medicine Faces Bitopertin FDA Setback, Extends Cash Runway to 2029 Amid Increased Losses
ProForm 10-QIRON · Form 10-Q · 4d ago
Valaris Reports Q1 Loss and Revenue Decline, Offset by Significant Backlog Growth and Merger Update
Form 10-QVAL · Form 10-Q · 4d ago
Disc Medicine Reports Strong Q1 Clinical Progress and $730M Cash Position, Extending Runway into 2029
ProForm 8-KIRON · Form 8-K · 4d ago
Global Indemnity Group Swings to Profit in Q1 2026 with Strong Underwriting Improvement
ProForm 8-KGBLI · Form 8-K · 4d ago
ChoiceOne Financial Services Releases Comprehensive Q1 2026 Investor Presentation
Form 8-KCOFS · Form 8-K · 4d ago
Minerva Neurosciences Reports Massive Q1 Loss Driven by Warrant Liability, Initiates Key Phase 3 Trial
ProForm 10-QNERV · Form 10-Q · 4d ago
Shareholders to Vote on Anti-Takeover Charter Amendment and Address Recurring Insider Reporting Failures
ProForm PRE 14AMDRR · Form PRE 14A · 4d ago
Toro Corp. Initiates Special Dividend Election Process with Favorable Stock Valuation
Form 6-KTORO · Form 6-K · 4d ago
Microbot Medical's LIBERTY Robotic System Gains Traction with New Account Wins
Form 8-KMBOT · Form 8-K · 4d ago
Enhabit Faces Shareholder Lawsuits Challenging Kinderhook Merger, Updates Proxy with New Financial Projections
ProForm 8-KEHAB · Form 8-K · 4d ago
Ballard Power Systems Reports Strong Q1 2026 Results with Improved Margins, Reduced Losses, and Major New Order
ProForm 6-KBLDP · Form 6-K · 4d ago
Q1 2026 Results Highlight Strong Cash Runway and Bezuclastinib Progress Towards Commercial Launch
ProForm 10-QCOGT · Form 10-Q · 4d ago
FS KKR Capital Seeks Shareholder Approval for Dilutive Capital Raising Flexibility
ProForm DEFA14AFSK · Form DEFA14A · 4d ago
Lithium Americas Appoints Former Rio Tinto Executive Clayton Walker to Board of Directors
Form 8-KLAC · Form 8-K · 4d ago
Silicom Secures Major AI Inference PoC with Potential for Tens of Thousands of Units
ProForm 6-KSILC · Form 6-K · 4d ago
Southwest Gas Reports Strong Q1 Earnings, Hikes Dividend, and Secures Key Regulatory Approvals for Major Projects
ProForm 10-QSWX · Form 10-Q · 4d ago
Minerva Neurosciences Reports Massive Q1 Net Loss of $125.4M Driven by Warrant Liability, Advances Phase 3 Trial
ProForm 8-KNERV · Form 8-K · 4d ago
Cogent Biosciences Advances Bezuclastinib with Multiple FDA Filings, Sets PDUFA Date, and Secures Cash Runway into 2028
ProForm 8-KCOGT · Form 8-K · 4d ago
Associated Banc-Corp Updates Acquisition Integration Timeline, Projects Strong FY2026 Growth
Form 8-KASB · Form 8-K · 4d ago
Frontier Group Reports Massive Q1 Loss of $272M, Driven by Fleet Restructuring & Regulatory Charges; New CEO Takes Helm
ProForm 10-QULCC · Form 10-Q · 4d ago
Southwest Gas Reports Strong Q1 Earnings, Affirms Full-Year Guidance, and Boosts Dividend
ProForm 8-KSWX · Form 8-K · 4d ago
Neuronetics Reports Improved Q1 Financials and Major Insurance Policy Expansion
Form 8-KSTIM · Form 8-K · 4d ago
Portillo's Reports Q1 Net Loss, Significant Profit Decline, Negative Same-Restaurant Sales, and CFO Departure
ProForm 10-QPTLO · Form 10-Q · 4d ago
Frontier Reports Deep Q1 GAAP Loss of $272M Amid Special Charges; Adjusted EPS Beats Guidance, Q2 Outlook Mixed
ProForm 8-KULCC · Form 8-K · 4d ago
Portillo's Reports Q1 Net Loss, Significant Profit Decline, and CFO Departure Amid Strategic Reset
ProForm 8-KPTLO · Form 8-K · 4d ago
Graphic Packaging Reports Q1 Net Loss, Announces Major Restructuring & Reaffirms Full-Year Guidance
Form 8-KGPK · Form 8-K · 4d ago
Zentalis Doses First Patient in Phase 3 ASPENOVA Trial for Ovarian Cancer Drug Azenosertib
ProForm 8-KZNTL · Form 8-K · 4d ago